114 related articles for article (PubMed ID: 38193945)
1. Comparative E-cadherin and syndecan-1 protein expression in human and canine oral squamous cell carcinoma.
Tabtieang SP; Paphussaro W; Rungsipipat A; Kunnasut N; Ploypetch S; Phattarataratip E; Suriyaphol G
Acta Vet Hung; 2024 Jan; 71(3-4):202-209. PubMed ID: 38193945
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiles of cell adhesion molecules, matrix metalloproteinases and their tissue inhibitors in canine oral tumors.
Pisamai S; Rungsipipat A; Kalpravidh C; Suriyaphol G
Res Vet Sci; 2017 Aug; 113():94-100. PubMed ID: 28918236
[TBL] [Abstract][Full Text] [Related]
3. Expression of syndecan-1 in oral cavity squamous cell carcinoma.
Woźniak M; Nahajowski M; Hnitecka S; Rutkowska M; Nowak M; Mitelsztet P; Szkudlarek D; Makuch S
J Histotechnol; 2021 Mar; 44(1):46-51. PubMed ID: 33357145
[TBL] [Abstract][Full Text] [Related]
4. Follistatin-related protein 1 interacting partner of Syndecan-1 promotes an aggressive phenotype on Oral Squamous cell carcinoma (OSCC) models.
Zandonadi FS; Yokoo S; Granato DC; Rivera C; Macedo CCS; Soares CD; Carnielli CM; Domingues RR; Pauletti BA; Consonni SR; Colleta RD; Paes Leme AF
J Proteomics; 2022 Mar; 254():104474. PubMed ID: 34990821
[TBL] [Abstract][Full Text] [Related]
5. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
[TBL] [Abstract][Full Text] [Related]
6. Molecular homology between canine spontaneous oral squamous cell carcinomas and human head-and-neck squamous cell carcinomas reveals disease drivers and therapeutic vulnerabilities.
Guscetti F; Nassiri S; Beebe E; Rito Brandao I; Graf R; Markkanen E
Neoplasia; 2020 Dec; 22(12):778-788. PubMed ID: 33142242
[TBL] [Abstract][Full Text] [Related]
7. Expression of syndecan-1 in different grades of oral squamous cell carcinoma: An immunohistochemical study.
Shetty PK; Gonsalves N; Desai D; Pandit S; Aradhya C; Shahid M; Shubhalakshmi ; Shetty SJ
J Cancer Res Ther; 2022 Dec; 18(Supplement):S191-S196. PubMed ID: 36510963
[TBL] [Abstract][Full Text] [Related]
8. Role of E-cadherin in Progression of Oral Squamous Cell Carcinoma: A Retrospective Immunohistochemical Study.
Gupta A; Sharma S; Batra M; Abidullah M; Bhuvinder S; Katragadda P
J Contemp Dent Pract; 2018 Sep; 19(9):1105-1110. PubMed ID: 30287712
[TBL] [Abstract][Full Text] [Related]
9. E-Cadherin Expression in Canine Melanocytic Tumors: Histological, Immunohistochemical, and Survival Analysis.
Silvestri S; Porcellato I; Mechelli L; Menchetti L; Iussich S; De Maria R; Sforna M; Bongiovanni L; Brachelente C
Vet Pathol; 2020 Sep; 57(5):608-619. PubMed ID: 32578507
[TBL] [Abstract][Full Text] [Related]
10. Highly recurrent BRAF p.V595E mutation in canine papillary oral squamous cell carcinoma.
Peralta S; Webb SM; Katt WP; Grenier JK; Duhamel GE
Vet Comp Oncol; 2023 Mar; 21(1):138-144. PubMed ID: 36451536
[TBL] [Abstract][Full Text] [Related]
11. Syndecan-1 suppresses epithelial-mesenchymal transition and migration in human oral cancer cells.
Wang X; He J; Zhao X; Qi T; Zhang T; Kong C
Oncol Rep; 2018 Apr; 39(4):1835-1842. PubMed ID: 29484435
[TBL] [Abstract][Full Text] [Related]
12. Epithelial and stromal syndecan-1 and -2 are distinctly expressed in oral- and cutaneous squamous cell carcinomas.
Ahmed Haji Omar A; Haglund C; Virolainen S; Häyry V; Atula T; Kontio R; Rihtniemi J; Pihakari A; Salo T; Hagström J; Sorsa T
J Oral Pathol Med; 2013 May; 42(5):389-95. PubMed ID: 23278563
[TBL] [Abstract][Full Text] [Related]
13. HMGA1 and HMGA2 expression and comparative analyses of HMGA2, Lin28 and let-7 miRNAs in oral squamous cell carcinoma.
Sterenczak KA; Eckardt A; Kampmann A; Willenbrock S; Eberle N; Länger F; Kleinschmidt S; Hewicker-Trautwein M; Kreipe H; Nolte I; Murua Escobar H; Gellrich NC
BMC Cancer; 2014 Sep; 14():694. PubMed ID: 25245141
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of homeodomain-interacting protein kinase 2 promotes oral squamous cell carcinoma metastasis through inhibition of P53-dependent E-cadherin expression.
Zheng X; Pan Y; Chen X; Xia S; Hu Y; Zhou Y; Zhang J
Cancer Sci; 2021 Jan; 112(1):117-132. PubMed ID: 33063904
[TBL] [Abstract][Full Text] [Related]
15. Establishing cell lines for canine tonsillar and non-tonsillar oral squamous cell carcinoma and identifying characteristics associated with malignancy.
Noguchi S; Hattori A; Tanimoto N; Nishida R; Hirano K; Wada Y; Matsuyama S; Shimada T; Akiyoshi H
Tissue Cell; 2020 Dec; 67():101408. PubMed ID: 32835941
[TBL] [Abstract][Full Text] [Related]
16. Invasive Front Grading and Epithelial-Mesenchymal Transition in Canine Oral and Cutaneous Squamous Cell Carcinomas.
Nagamine E; Hirayama K; Matsuda K; Okamoto M; Ohmachi T; Uchida K; Kadosawa T; Taniyama H
Vet Pathol; 2017 Sep; 54(5):783-791. PubMed ID: 28494700
[TBL] [Abstract][Full Text] [Related]
17. Subcellular localization and expression of E-cadherin and SNAIL are relevant since early stages of oral carcinogenesis.
Lopes NM; Xavier FCA; Ortiz RC; Amôr NG; Garlet GP; Lara VS; Batista AC; Costa NL; Rodini CO
Pathol Res Pract; 2018 Aug; 214(8):1185-1191. PubMed ID: 29970306
[TBL] [Abstract][Full Text] [Related]
18. [Expression of Tyrosine Kinase Receptor 2 in Oral Squamous Cell Carcinoma and the Effect on Cell Proliferation and Migration and Epithelial-Mesenchymal Transition Process].
Zheng M; Huang Y; Fei W; Shen Y; Nie X; Gao MY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):342-349. PubMed ID: 36949696
[TBL] [Abstract][Full Text] [Related]
19. SLUG is upregulated and induces epithelial mesenchymal transition in canine oral squamous cell carcinoma.
Noguchi S; Hirano K; Tanimoto N; Shimada T; Akiyoshi H
Vet Comp Oncol; 2022 Mar; 20(1):134-141. PubMed ID: 34310030
[TBL] [Abstract][Full Text] [Related]
20. Expressional variations of Kaiso: an association with pathological characteristics and field cancerization of OSCC.
Ahmed S; Khan S; Qureshi MA; Bukhari U; Anis M; Mughal MN
BMC Cancer; 2022 Sep; 22(1):990. PubMed ID: 36115941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
